These data demonstrate that human cells can generate immunogenic epitopes from the INS-splice polypeptide that are processed and presented to patient-derived cytolytic T cells, suggesting that INS-splice-expressing delta cells may be targeted by autoreactive T cells in type 1 diabetes immunopathology. The gene discussed is INS; the disease is type 1 diabetes mellitus.